Top 15% of pharmacy schools
The future of pharmacy starts here.
At the Skaggs School of Pharmacy, students from around the globe learn from award-winning faculty in a world-class medical setting. Hands-on training is dynamic, interprofessional and career-driven. From our entry-level PharmD program to flexible online degrees, our curriculum is innovative and agile, preparing students to be leaders in the emerging pharmacy careers of the future.
Explore Our Programs
PharmD Program
Interprofessional and experiential. From hospitals and industry settings, to clinics and pharmacies, our PharmD graduates are taking the lead optimizing medications and improving patient care.
Online Programs
We’ve been offering online degrees for more than 20 years. And it shows. Our online degrees and certificates deliver academic rigor in a flexible, interactive setting.
Master's Programs
Whether it’s a Master’s in Clinical Pharmacy, Pharmaceutical Sciences, or Palliative Care, adding an MS to your toolkit will deepen your patient-centered skills and increase your professional opportunities.
Top 10% in NIH funding
92% first-time NAPLEX pass rate
More than 1,300 rotation sites
95% of grads employed within 6 months
7 ACCP national award winners
Explore Our Campus
Learn on an Interprofessional Team
From the first week on campus, you’ll engage in experiential and interprofessional training that prepares you for team-based pharmacy careers.
Upcoming Events
Alumna Shows Drive and Initiative in Identifying a Pharmacy Career
2019 CU Pharmacy alumna Jennifer Kobylarczyk describes how she carved out a career path as a consultant pharmacist combining her expertise in compounding and veterinary pharmacy in the latest alumni careers spotlight.
Would You Like a Sundae With that Prescription?
Alumnus Lucas Smith, PharmD, and his wife Jill were recently featured in the Gazette for their ownership and transformation of a small pharmacy. Lucas is also a scholarship recipient, and is proudly supporting this fall's 1911 Scholarship Fund.
New Pill Is a Potential Game-Changer in the COVID Battle, CU Anschutz Expert Says
Professor Peter Anderson, PharmD, served as the featured expert in this story about the first antiviral pill to treat COVID-19. In the story, Peter describes molnupiravir‘s efficacy as “a very exciting development” and expects that oral pills taken at home, in combination with other medications, will be the future of COVID treatments.
School of Pharmacy Joins Nationwide Medication/Vaccine Initiative
CU Pharmacy has joined the RAPID Alliance Medications 360 Study as a University Research Partner to transform how medications and vaccines are delivered in the US from. If you are a key stakeholder interested in optimizing medications and vaccine use, please join us to help co-create the RAPID Alliance Medications 360 Strategic Framework 2022-2031.
Demand at pharmacies ramps up as COVID-19 vaccine booster shots approved
Associate professor and executive director of the Colorado Pharmacists Society, Emily Zadvorny, PharmD appeared on Channel 9 News to discuss the heightened demands that pharmacies are experiencing as more people seek out COVID boosters.
Robotic technology takes us into a new era of drug discovery
A cutting-edge robot that will cut screening time for new drugs in half to get more effective therapies to people and animals is busy doing lifesaving work. Professor Dan LaBarbera, PhD is the founding director of the Center for Drug Discovery at CU Anschutz.
New tool to help speed up life-saving drug treatments
The new Center for Drug Discovery was featured on Channel 9 news. On the day of its airing the story, titled “New tool to help speed up life-saving drug treatments,” received the most views on the station’s Youtube channel!
How COVID-19 Variants Could Outsmart Vaccines
Professor Krishna Mallela, PhD, along with Vaibhav Upadhyay, Alexandra Lucas, Sudipta Panja, and Ryuki Miyauchi had research published in the Journal of Biological Chemistry. Dr. Mallela was also featured in this Discover magazine article title, “How COVID-19 Variants Could Outsmart Vaccines,” in which he discusses the implications of this research.